IL-1, IL-6, and TNF were recently shown to promote deregulation of erythropoietin with resultant anemia in acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS) [35, 36]. Here, EPO is linked to myelodysplastic syndrome.